Rank | Gene Set | Z-score |
---|---|---|
1 | protein maturation by protein folding (GO:0022417) | 5.44247694 |
2 | Golgi transport vesicle coating (GO:0048200) | 5.17329349 |
3 | COPI coating of Golgi vesicle (GO:0048205) | 5.17329349 |
4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.68381264 |
5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.68381264 |
6 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.30242435 |
7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.10027311 |
8 | DNA unwinding involved in DNA replication (GO:0006268) | 3.94890234 |
9 | GDP-mannose metabolic process (GO:0019673) | 3.93722050 |
10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.86144186 |
11 | establishment of viral latency (GO:0019043) | 3.83319097 |
12 | regulation of mitochondrial translation (GO:0070129) | 3.80399990 |
13 | establishment of integrated proviral latency (GO:0075713) | 3.79202651 |
14 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.65711985 |
15 | iron-sulfur cluster assembly (GO:0016226) | 3.65166485 |
16 | metallo-sulfur cluster assembly (GO:0031163) | 3.65166485 |
17 | definitive hemopoiesis (GO:0060216) | 3.57273562 |
18 | pinocytosis (GO:0006907) | 3.48510123 |
19 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.41783548 |
20 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.39907781 |
21 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.36491999 |
22 | protein retention in ER lumen (GO:0006621) | 3.33453796 |
23 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.31452009 |
24 | mannosylation (GO:0097502) | 3.28659090 |
25 | negative regulation of B cell apoptotic process (GO:0002903) | 3.28298851 |
26 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 3.26298984 |
27 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.24852868 |
28 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.23200240 |
29 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.23200240 |
30 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.20788548 |
31 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.20788548 |
32 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.20788548 |
33 | nuclear pore complex assembly (GO:0051292) | 3.19064428 |
34 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.18767469 |
35 | NADPH regeneration (GO:0006740) | 3.16135251 |
36 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.15610211 |
37 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.15610211 |
38 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 3.14733238 |
39 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.13272555 |
40 | GMP metabolic process (GO:0046037) | 3.09451220 |
41 | regulation of gamma-delta T cell activation (GO:0046643) | 3.08821987 |
42 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.08332180 |
43 | glucose catabolic process (GO:0006007) | 3.08142564 |
44 | negative regulation of phagocytosis (GO:0050765) | 3.06061677 |
45 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.00561070 |
46 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.99155413 |
47 | regulation of protein heterodimerization activity (GO:0043497) | 2.96784523 |
48 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.96252109 |
49 | morphogenesis of an endothelium (GO:0003159) | 2.95840285 |
50 | endothelial tube morphogenesis (GO:0061154) | 2.95840285 |
51 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.94181521 |
52 | nuclear pore organization (GO:0006999) | 2.93430688 |
53 | plasma lipoprotein particle assembly (GO:0034377) | 2.91410712 |
54 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.91123232 |
55 | negative regulation of ligase activity (GO:0051352) | 2.91123232 |
56 | viral transcription (GO:0019083) | 2.86482070 |
57 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.84876157 |
58 | pentose metabolic process (GO:0019321) | 2.84302919 |
59 | formation of translation preinitiation complex (GO:0001731) | 2.84234334 |
60 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.83253329 |
61 | base-excision repair (GO:0006284) | 2.81527764 |
62 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.80564322 |
63 | proline biosynthetic process (GO:0006561) | 2.79888370 |
64 | translational termination (GO:0006415) | 2.78795211 |
65 | mitotic nuclear envelope reassembly (GO:0007084) | 2.77293824 |
66 | nuclear envelope reassembly (GO:0031468) | 2.77293824 |
67 | base-excision repair, AP site formation (GO:0006285) | 2.77217769 |
68 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.72945538 |
69 | snRNA processing (GO:0016180) | 2.72727150 |
70 | ribosomal small subunit assembly (GO:0000028) | 2.72533403 |
71 | regulation of cholesterol esterification (GO:0010872) | 2.71958174 |
72 | peptidyl-arginine N-methylation (GO:0035246) | 2.70743465 |
73 | peptidyl-arginine methylation (GO:0018216) | 2.70743465 |
74 | establishment of endothelial barrier (GO:0061028) | 2.68845266 |
75 | deoxyribonucleotide catabolic process (GO:0009264) | 2.68453966 |
76 | branched-chain amino acid catabolic process (GO:0009083) | 2.67964090 |
77 | protein deneddylation (GO:0000338) | 2.67828525 |
78 | glycolytic process (GO:0006096) | 2.67512212 |
79 | protein localization to kinetochore (GO:0034501) | 2.67476565 |
80 | UV protection (GO:0009650) | 2.66804737 |
81 | positive regulation of cell cycle arrest (GO:0071158) | 2.66553929 |
82 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.65838146 |
83 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.65696977 |
84 | cellular response to interleukin-4 (GO:0071353) | 2.65247279 |
85 | negative regulation of cell size (GO:0045792) | 2.64381063 |
86 | T cell apoptotic process (GO:0070231) | 2.64323802 |
87 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.64215226 |
88 | proteasome assembly (GO:0043248) | 2.62749511 |
89 | positive regulation of B cell differentiation (GO:0045579) | 2.62291900 |
90 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.61905673 |
91 | mitotic nuclear envelope disassembly (GO:0007077) | 2.61686062 |
92 | leukocyte aggregation (GO:0070486) | 2.61276796 |
93 | GPI anchor biosynthetic process (GO:0006506) | 2.60631967 |
94 | lymph vessel development (GO:0001945) | 2.59772570 |
95 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.57540900 |
96 | DNA strand elongation (GO:0022616) | 2.57403255 |
97 | deoxyribose phosphate catabolic process (GO:0046386) | 2.56822973 |
98 | regulation of translation in response to stress (GO:0043555) | 2.56511840 |
99 | positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552) | 2.55733080 |
100 | negative T cell selection (GO:0043383) | 2.55308432 |
101 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.54992802 |
102 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 2.54570541 |
103 | regulation of cell cycle arrest (GO:0071156) | 2.53160533 |
104 | germ cell migration (GO:0008354) | 2.52646878 |
105 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.52387011 |
106 | translational elongation (GO:0006414) | 2.52121080 |
107 | sprouting angiogenesis (GO:0002040) | 2.51521310 |
108 | regulation of superoxide anion generation (GO:0032928) | 2.51353273 |
109 | snRNA metabolic process (GO:0016073) | 2.50879126 |
110 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.50296614 |
111 | dosage compensation (GO:0007549) | 2.50157854 |
112 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.50004311 |
113 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.49483031 |
114 | membrane disassembly (GO:0030397) | 2.48858587 |
115 | nuclear envelope disassembly (GO:0051081) | 2.48858587 |
116 | angiogenesis involved in wound healing (GO:0060055) | 2.48188392 |
117 | negative thymic T cell selection (GO:0045060) | 2.48174772 |
118 | pore complex assembly (GO:0046931) | 2.47815597 |
119 | viral mRNA export from host cell nucleus (GO:0046784) | 2.46237682 |
120 | galactose catabolic process (GO:0019388) | 2.45994764 |
121 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.45397463 |
122 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.44704537 |
123 | NIK/NF-kappaB signaling (GO:0038061) | 2.44051281 |
124 | maturation of SSU-rRNA (GO:0030490) | 2.43906342 |
125 | nucleotide salvage (GO:0043173) | 2.43829660 |
126 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.42176500 |
127 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.42051933 |
128 | response to interleukin-15 (GO:0070672) | 2.41430990 |
129 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.41414057 |
130 | positive regulation of ligase activity (GO:0051351) | 2.41078373 |
131 | pentose-phosphate shunt (GO:0006098) | 2.41051560 |
132 | cullin deneddylation (GO:0010388) | 2.41013835 |
133 | protein-lipid complex assembly (GO:0065005) | 2.38922441 |
134 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.38498427 |
135 | histone arginine methylation (GO:0034969) | 2.37949420 |
136 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.37511146 |
137 | lipopolysaccharide metabolic process (GO:0008653) | 2.37249135 |
138 | tricarboxylic acid metabolic process (GO:0072350) | 2.36747106 |
139 | actin nucleation (GO:0045010) | 2.36546291 |
140 | response to laminar fluid shear stress (GO:0034616) | 2.36393588 |
141 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.35735851 |
142 | 4-hydroxyproline metabolic process (GO:0019471) | 2.35185379 |
143 | virion assembly (GO:0019068) | 2.34955029 |
144 | patterning of blood vessels (GO:0001569) | 2.34864524 |
145 | pyrimidine nucleoside salvage (GO:0043097) | 2.33862657 |
146 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.33478509 |
147 | negative regulation of RNA splicing (GO:0033119) | 2.32919226 |
148 | regulation of B cell differentiation (GO:0045577) | 2.31843676 |
149 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.31232609 |
150 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.31187405 |
151 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.29783608 |
152 | response to UV-C (GO:0010225) | 2.29613087 |
153 | positive regulation of lipid kinase activity (GO:0090218) | 2.29329599 |
154 | mRNA transcription (GO:0009299) | 2.28723659 |
155 | endodermal cell differentiation (GO:0035987) | 2.28678395 |
156 | mitotic recombination (GO:0006312) | 2.27824007 |
157 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.26399871 |
158 | radial glial cell differentiation (GO:0060019) | 2.23862815 |
159 | positive regulation of epithelial to mesenchymal transition (GO:0010718) | 2.23273257 |
160 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.22498424 |
161 | DNA duplex unwinding (GO:0032508) | 2.21285215 |
162 | positive thymic T cell selection (GO:0045059) | 2.20630115 |
163 | telomere maintenance via recombination (GO:0000722) | 2.20492671 |
164 | IMP biosynthetic process (GO:0006188) | 2.20128361 |
165 | DNA replication initiation (GO:0006270) | 2.20089767 |
166 | viral life cycle (GO:0019058) | 2.19764112 |
167 | histone mRNA catabolic process (GO:0071044) | 2.19153150 |
168 | DNA geometric change (GO:0032392) | 2.18928406 |
169 | translational initiation (GO:0006413) | 2.17836925 |
170 | immunoglobulin mediated immune response (GO:0016064) | 2.17065629 |
171 | B cell mediated immunity (GO:0019724) | 2.16107578 |
172 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.15077626 |
173 | lymphocyte apoptotic process (GO:0070227) | 2.14266862 |
174 | thymic T cell selection (GO:0045061) | 2.12508702 |
175 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.11494350 |
176 | negative regulation of interleukin-12 production (GO:0032695) | 2.09459655 |
177 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.08765196 |
178 | protein localization to chromosome, centromeric region (GO:0071459) | 2.08311435 |
179 | cellular protein complex disassembly (GO:0043624) | 2.08287927 |
180 | translesion synthesis (GO:0019985) | 2.08071827 |
181 | natural killer cell differentiation (GO:0001779) | 2.07513228 |
182 | sequestering of actin monomers (GO:0042989) | 2.07094624 |
183 | trabecula morphogenesis (GO:0061383) | 2.06196056 |
184 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.05139626 |
185 | mitotic chromosome condensation (GO:0007076) | 2.04474298 |
186 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.03545198 |
187 | negative regulation of stress fiber assembly (GO:0051497) | 2.02955103 |
188 | chondrocyte proliferation (GO:0035988) | 2.02606990 |
189 | T cell homeostasis (GO:0043029) | 2.01631824 |
190 | protein targeting to ER (GO:0045047) | 2.01048882 |
191 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.01044657 |
192 | regulation of phosphatidylinositol 3-kinase activity (GO:0043551) | 2.00359723 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.26694405 |
2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.97985712 |
3 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.56646209 |
4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.44580403 |
5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.02860258 |
6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.01064263 |
7 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.98102061 |
8 | MYC_22102868_ChIP-Seq_BL_Human | 2.90418493 |
9 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.89298776 |
10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.86801666 |
11 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.64607488 |
12 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.50853767 |
13 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.35540532 |
14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.34945710 |
15 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.30090164 |
16 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.14368358 |
17 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.11053926 |
18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.10712490 |
19 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.10567416 |
20 | * GABP_19822575_ChIP-Seq_HepG2_Human | 2.10243698 |
21 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.08486294 |
22 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.02338843 |
23 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.00262629 |
24 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.98087231 |
25 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.97146142 |
26 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.97085315 |
27 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.91712075 |
28 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.89653677 |
29 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.89242610 |
30 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.88623671 |
31 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.86852084 |
32 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.86728937 |
33 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.85095177 |
34 | MAF_26560356_Chip-Seq_TH1_Human | 1.84980563 |
35 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.84510901 |
36 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.80953770 |
37 | MYB_26560356_Chip-Seq_TH2_Human | 1.80695436 |
38 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.78838218 |
39 | UTX_26944678_Chip-Seq_JUKART_Human | 1.76057182 |
40 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.75605842 |
41 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.75597987 |
42 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.71192050 |
43 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.70893218 |
44 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.67766662 |
45 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66124441 |
46 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.66098880 |
47 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.63611245 |
48 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.61580271 |
49 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.59436168 |
50 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.57317494 |
51 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.50696179 |
52 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.49855372 |
53 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.49422085 |
54 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.49039359 |
55 | MYB_26560356_Chip-Seq_TH1_Human | 1.49010441 |
56 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.48119002 |
57 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.47764846 |
58 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.47418940 |
59 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.45306302 |
60 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.44943830 |
61 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.44737748 |
62 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.44232000 |
63 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.41819573 |
64 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.41548634 |
65 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41547955 |
66 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.41489438 |
67 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.38954474 |
68 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38808027 |
69 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.37358150 |
70 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.36892632 |
71 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.36837772 |
72 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36761064 |
73 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.36475432 |
74 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.36239094 |
75 | MAF_26560356_Chip-Seq_TH2_Human | 1.34977823 |
76 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.33747258 |
77 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.33718256 |
78 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.33682231 |
79 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.33127151 |
80 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.32824030 |
81 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.31617890 |
82 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.30367310 |
83 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.30280548 |
84 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30230631 |
85 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.28812970 |
86 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.28604426 |
87 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.27311992 |
88 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.24928549 |
89 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.24178736 |
90 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.22632181 |
91 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.22384621 |
92 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.22199664 |
93 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.22060612 |
94 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.21924430 |
95 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21718285 |
96 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.20893209 |
97 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.20084384 |
98 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.18915964 |
99 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18640968 |
100 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.18523719 |
101 | P68_20966046_ChIP-Seq_HELA_Human | 1.17755531 |
102 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.17672308 |
103 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.16151498 |
104 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.16100256 |
105 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.15459720 |
106 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.13891316 |
107 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.13609968 |
108 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.13340177 |
109 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.13220310 |
110 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.11914377 |
111 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.11708073 |
112 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.11182911 |
113 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.10780027 |
114 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.10611416 |
115 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.09960267 |
116 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08828133 |
117 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.08561845 |
118 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.08321246 |
119 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.07730617 |
120 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.07411343 |
121 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.06555030 |
122 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.06300549 |
123 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.06300549 |
124 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05564447 |
125 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.05351904 |
126 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.04808160 |
127 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.04456275 |
128 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.04172936 |
129 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.04059107 |
130 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.03925764 |
131 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.03004190 |
132 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.02890196 |
133 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.01982184 |
134 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.01811196 |
135 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.01755420 |
136 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.00945788 |
137 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.00843854 |
138 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.00049031 |
139 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99811576 |
140 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.99476786 |
141 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.99083915 |
142 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.98859625 |
143 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.98482475 |
144 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.98330476 |
145 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98099158 |
146 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.98079030 |
147 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.96745508 |
148 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.96300529 |
149 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.95545224 |
150 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.95095274 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005058_abnormal_lysosome_morphology | 3.29010463 |
2 | MP0008438_abnormal_cutaneous_collagen | 3.16752454 |
3 | MP0003191_abnormal_cellular_cholesterol | 3.07166019 |
4 | MP0003122_maternal_imprinting | 2.88893022 |
5 | MP0010352_gastrointestinal_tract_polyps | 2.72222876 |
6 | MP0003172_abnormal_lysosome_physiology | 2.62792106 |
7 | MP0008260_abnormal_autophagy | 2.45113679 |
8 | MP0005075_abnormal_melanosome_morpholog | 2.40377382 |
9 | MP0003279_aneurysm | 2.36311182 |
10 | MP0000372_irregular_coat_pigmentation | 2.33547007 |
11 | MP0004808_abnormal_hematopoietic_stem | 2.31450696 |
12 | MP0006054_spinal_hemorrhage | 2.28383971 |
13 | MP0003705_abnormal_hypodermis_morpholog | 2.20877297 |
14 | MP0003806_abnormal_nucleotide_metabolis | 2.17401637 |
15 | MP0002396_abnormal_hematopoietic_system | 2.13222300 |
16 | MP0003123_paternal_imprinting | 2.12240023 |
17 | MP0005275_abnormal_skin_tensile | 2.08230570 |
18 | MP0003566_abnormal_cell_adhesion | 2.04047961 |
19 | MP0002166_altered_tumor_susceptibility | 2.00604060 |
20 | MP0003763_abnormal_thymus_physiology | 2.00222112 |
21 | MP0003436_decreased_susceptibility_to | 1.96769274 |
22 | MP0008007_abnormal_cellular_replicative | 1.96124131 |
23 | MP0009840_abnormal_foam_cell | 1.92825089 |
24 | MP0001958_emphysema | 1.85743360 |
25 | MP0001835_abnormal_antigen_presentation | 1.82845856 |
26 | MP0003077_abnormal_cell_cycle | 1.81497945 |
27 | MP0000685_abnormal_immune_system | 1.80826508 |
28 | MP0003786_premature_aging | 1.78791287 |
29 | MP0009333_abnormal_splenocyte_physiolog | 1.78531317 |
30 | MP0002877_abnormal_melanocyte_morpholog | 1.75934740 |
31 | MP0009278_abnormal_bone_marrow | 1.75485205 |
32 | MP0005023_abnormal_wound_healing | 1.73928318 |
33 | MP0001879_abnormal_lymphatic_vessel | 1.68297836 |
34 | MP0002006_tumorigenesis | 1.66486434 |
35 | MP0005397_hematopoietic_system_phenotyp | 1.66007899 |
36 | MP0001545_abnormal_hematopoietic_system | 1.66007899 |
37 | MP0003315_abnormal_perineum_morphology | 1.62897889 |
38 | MP0005451_abnormal_body_composition | 1.62501016 |
39 | MP0002398_abnormal_bone_marrow | 1.62144279 |
40 | MP0003300_gastrointestinal_ulcer | 1.61218239 |
41 | MP0005503_abnormal_tendon_morphology | 1.60323236 |
42 | MP0003693_abnormal_embryo_hatching | 1.60079489 |
43 | MP0001800_abnormal_humoral_immune | 1.59403345 |
44 | MP0008057_abnormal_DNA_replication | 1.58361771 |
45 | MP0003111_abnormal_nucleus_morphology | 1.55395515 |
46 | MP0003121_genomic_imprinting | 1.51686997 |
47 | MP0002132_abnormal_respiratory_system | 1.51648893 |
48 | MP0010094_abnormal_chromosome_stability | 1.49654431 |
49 | MP0005408_hypopigmentation | 1.49194603 |
50 | MP0000358_abnormal_cell_content/ | 1.47638038 |
51 | MP0002452_abnormal_antigen_presenting | 1.46276936 |
52 | MP0002420_abnormal_adaptive_immunity | 1.46240696 |
53 | MP0003303_peritoneal_inflammation | 1.45002611 |
54 | MP0002405_respiratory_system_inflammati | 1.44942162 |
55 | MP0000858_altered_metastatic_potential | 1.44600391 |
56 | MP0001819_abnormal_immune_cell | 1.43353482 |
57 | MP0005257_abnormal_intraocular_pressure | 1.42660428 |
58 | MP0004957_abnormal_blastocyst_morpholog | 1.40095945 |
59 | MP0002722_abnormal_immune_system | 1.39347095 |
60 | MP0000703_abnormal_thymus_morphology | 1.38287507 |
61 | MP0005076_abnormal_cell_differentiation | 1.37375287 |
62 | MP0002163_abnormal_gland_morphology | 1.36683634 |
63 | MP0000490_abnormal_crypts_of | 1.35881435 |
64 | MP0003091_abnormal_cell_migration | 1.35822626 |
65 | MP0000767_abnormal_smooth_muscle | 1.34895162 |
66 | MP0004264_abnormal_extraembryonic_tissu | 1.34837773 |
67 | MP0001790_abnormal_immune_system | 1.34769435 |
68 | MP0005387_immune_system_phenotype | 1.34769435 |
69 | MP0004272_abnormal_basement_membrane | 1.34148279 |
70 | MP0000733_abnormal_muscle_development | 1.32934362 |
71 | MP0005671_abnormal_response_to | 1.32780830 |
72 | MP0000689_abnormal_spleen_morphology | 1.32256922 |
73 | MP0005000_abnormal_immune_tolerance | 1.31357186 |
74 | MP0010307_abnormal_tumor_latency | 1.30799753 |
75 | MP0000350_abnormal_cell_proliferation | 1.30570777 |
76 | MP0009785_altered_susceptibility_to | 1.29394167 |
77 | MP0000716_abnormal_immune_system | 1.28155260 |
78 | MP0003448_altered_tumor_morphology | 1.27341006 |
79 | MP0002723_abnormal_immune_serum | 1.25056851 |
80 | MP0002429_abnormal_blood_cell | 1.24101473 |
81 | MP0003878_abnormal_ear_physiology | 1.23276228 |
82 | MP0005377_hearing/vestibular/ear_phenot | 1.23276228 |
83 | MP0001730_embryonic_growth_arrest | 1.22244706 |
84 | MP0003724_increased_susceptibility_to | 1.21433005 |
85 | MP0002938_white_spotting | 1.20755561 |
86 | MP0000371_diluted_coat_color | 1.19684973 |
87 | MP0001915_intracranial_hemorrhage | 1.19506275 |
88 | MP0001764_abnormal_homeostasis | 1.18295392 |
89 | MP0005464_abnormal_platelet_physiology | 1.16624551 |
90 | MP0005025_abnormal_response_to | 1.16355941 |
91 | MP0002419_abnormal_innate_immunity | 1.15436511 |
92 | MP0005084_abnormal_gallbladder_morpholo | 1.14627128 |
93 | MP0010155_abnormal_intestine_physiology | 1.14162028 |
94 | MP0002933_joint_inflammation | 1.13471594 |
95 | MP0001533_abnormal_skeleton_physiology | 1.11320412 |
96 | MP0001661_extended_life_span | 1.11263945 |
97 | MP0001853_heart_inflammation | 1.10862145 |
98 | MP0005623_abnormal_meninges_morphology | 1.09000432 |
99 | MP0002019_abnormal_tumor_incidence | 1.07493125 |
100 | MP0010368_abnormal_lymphatic_system | 1.07252500 |
101 | MP0005360_urolithiasis | 1.07023303 |
102 | MP0002086_abnormal_extraembryonic_tissu | 1.05871200 |
103 | MP0005367_renal/urinary_system_phenotyp | 1.04433377 |
104 | MP0000516_abnormal_urinary_system | 1.04433377 |
105 | MP0002653_abnormal_ependyma_morphology | 1.03651425 |
106 | MP0003943_abnormal_hepatobiliary_system | 1.03026831 |
107 | MP0002075_abnormal_coat/hair_pigmentati | 1.02692496 |
108 | MP0003186_abnormal_redox_activity | 1.02556181 |
109 | MP0006035_abnormal_mitochondrial_morpho | 1.02281398 |
110 | MP0001243_abnormal_dermal_layer | 1.00905815 |
111 | MP0000598_abnormal_liver_morphology | 1.00159905 |
112 | MP0001873_stomach_inflammation | 0.98701207 |
113 | MP0009697_abnormal_copulation | 0.98242748 |
114 | MP0005083_abnormal_biliary_tract | 0.98236773 |
115 | MP0004947_skin_inflammation | 0.97786249 |
116 | MP0000465_gastrointestinal_hemorrhage | 0.96799174 |
117 | MP0000003_abnormal_adipose_tissue | 0.96773474 |
118 | MP0006292_abnormal_olfactory_placode | 0.96401319 |
119 | MP0002925_abnormal_cardiovascular_devel | 0.94725800 |
120 | MP0003984_embryonic_growth_retardation | 0.94431780 |
121 | MP0008058_abnormal_DNA_repair | 0.93196306 |
122 | MP0003567_abnormal_fetal_cardiomyocyte | 0.93130218 |
123 | MP0001697_abnormal_embryo_size | 0.92976600 |
124 | MP0002060_abnormal_skin_morphology | 0.92937014 |
125 | MP0001672_abnormal_embryogenesis/_devel | 0.92807876 |
126 | MP0005380_embryogenesis_phenotype | 0.92807876 |
127 | MP0002088_abnormal_embryonic_growth/wei | 0.92432798 |
128 | MP0008932_abnormal_embryonic_tissue | 0.91567909 |
129 | MP0009053_abnormal_anal_canal | 0.90354275 |
130 | MP0004197_abnormal_fetal_growth/weight/ | 0.90332451 |
131 | MP0005171_absent_coat_pigmentation | 0.89562024 |
132 | MP0010030_abnormal_orbit_morphology | 0.89449581 |
133 | MP0000609_abnormal_liver_physiology | 0.89229025 |
134 | MP0005390_skeleton_phenotype | 0.88822399 |
135 | MP0000015_abnormal_ear_pigmentation | 0.85977609 |
136 | MP0005384_cellular_phenotype | 0.85777260 |
137 | MP0001614_abnormal_blood_vessel | 0.84278874 |
138 | MP0001845_abnormal_inflammatory_respons | 0.84119861 |
139 | MP0008469_abnormal_protein_level | 0.82349125 |
140 | MP0005330_cardiomyopathy | 0.82220249 |
141 | MP0003866_abnormal_defecation | 0.82088378 |
142 | MP0005365_abnormal_bile_salt | 0.82005378 |
143 | MP0002148_abnormal_hypersensitivity_rea | 0.81676021 |
144 | MP0002128_abnormal_blood_circulation | 0.81175161 |
145 | MP0010329_abnormal_lipoprotein_level | 0.80588979 |
146 | MP0002080_prenatal_lethality | 0.79586551 |
147 | MP0000639_abnormal_adrenal_gland | 0.79548408 |
148 | MP0005220_abnormal_exocrine_pancreas | 0.78383460 |
149 | MP0001293_anophthalmia | 0.78293366 |
150 | MP0003950_abnormal_plasma_membrane | 0.77735677 |
151 | MP0003656_abnormal_erythrocyte_physiolo | 0.77475452 |
152 | MP0000313_abnormal_cell_death | 0.76678793 |
153 | MP0009384_cardiac_valve_regurgitation | 0.76642208 |
154 | MP0005508_abnormal_skeleton_morphology | 0.75826446 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Protrusio acetabuli (HP:0003179) | 4.26942283 |
2 | Abnormal gallbladder physiology (HP:0012438) | 3.87095646 |
3 | Cholecystitis (HP:0001082) | 3.87095646 |
4 | Abnormality of glycolysis (HP:0004366) | 3.66126735 |
5 | Entropion (HP:0000621) | 3.38596149 |
6 | Type I transferrin isoform profile (HP:0003642) | 3.37629603 |
7 | Premature rupture of membranes (HP:0001788) | 3.36990753 |
8 | Deep venous thrombosis (HP:0002625) | 3.26809432 |
9 | Increased serum pyruvate (HP:0003542) | 3.15655337 |
10 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 3.09896205 |
11 | Ankle contracture (HP:0006466) | 3.00943672 |
12 | Abnormal protein glycosylation (HP:0012346) | 3.00138882 |
13 | Abnormal glycosylation (HP:0012345) | 3.00138882 |
14 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.00138882 |
15 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.00138882 |
16 | Aortic dissection (HP:0002647) | 2.99113529 |
17 | Microvesicular hepatic steatosis (HP:0001414) | 2.98932132 |
18 | Aortic aneurysm (HP:0004942) | 2.90291357 |
19 | Dilatation of the ascending aorta (HP:0005111) | 2.89735337 |
20 | Cerebral aneurysm (HP:0004944) | 2.88880410 |
21 | Chronic otitis media (HP:0000389) | 2.82108632 |
22 | Recurrent viral infections (HP:0004429) | 2.79652986 |
23 | Hepatocellular necrosis (HP:0001404) | 2.71675086 |
24 | Increased density of long bones (HP:0006392) | 2.71590724 |
25 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.68674514 |
26 | Absent epiphyses (HP:0010577) | 2.68674514 |
27 | Recurrent bronchitis (HP:0002837) | 2.68005017 |
28 | Abnormal platelet volume (HP:0011876) | 2.64617630 |
29 | Broad alveolar ridges (HP:0000187) | 2.64031497 |
30 | Persistence of primary teeth (HP:0006335) | 2.62217456 |
31 | Nonimmune hydrops fetalis (HP:0001790) | 2.59350195 |
32 | Short 4th metacarpal (HP:0010044) | 2.58814461 |
33 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.58814461 |
34 | Poikiloderma (HP:0001029) | 2.58466375 |
35 | Shallow orbits (HP:0000586) | 2.57315633 |
36 | Severe combined immunodeficiency (HP:0004430) | 2.56153391 |
37 | Petechiae (HP:0000967) | 2.52895223 |
38 | Abnormality of the peritoneum (HP:0002585) | 2.50649673 |
39 | Peritonitis (HP:0002586) | 2.50266829 |
40 | Growth hormone excess (HP:0000845) | 2.49261518 |
41 | Pustule (HP:0200039) | 2.43913503 |
42 | Increased mean platelet volume (HP:0011877) | 2.42608931 |
43 | Selective tooth agenesis (HP:0001592) | 2.42423510 |
44 | Hepatic necrosis (HP:0002605) | 2.40949156 |
45 | Cellulitis (HP:0100658) | 2.40226001 |
46 | Prolonged neonatal jaundice (HP:0006579) | 2.39071427 |
47 | Delayed CNS myelination (HP:0002188) | 2.37387911 |
48 | Rough bone trabeculation (HP:0100670) | 2.37222555 |
49 | Recurrent fungal infections (HP:0002841) | 2.36980816 |
50 | T lymphocytopenia (HP:0005403) | 2.34903762 |
51 | Wrist flexion contracture (HP:0001239) | 2.34790640 |
52 | Hepatosplenomegaly (HP:0001433) | 2.33788849 |
53 | Spastic paraparesis (HP:0002313) | 2.33018786 |
54 | Abnormality of T cell number (HP:0011839) | 2.30841375 |
55 | Myositis (HP:0100614) | 2.30316280 |
56 | Glucose intolerance (HP:0000833) | 2.28821667 |
57 | Syringomyelia (HP:0003396) | 2.27643710 |
58 | Spinal cord lesions (HP:0100561) | 2.27643710 |
59 | Eczematoid dermatitis (HP:0000976) | 2.26840323 |
60 | Soft skin (HP:0000977) | 2.24723459 |
61 | Joint hemorrhage (HP:0005261) | 2.24574199 |
62 | Cervical subluxation (HP:0003308) | 2.24449846 |
63 | Broad metatarsal (HP:0001783) | 2.22913183 |
64 | Orthostatic hypotension (HP:0001278) | 2.22618522 |
65 | Cutaneous melanoma (HP:0012056) | 2.22242463 |
66 | Ragged-red muscle fibers (HP:0003200) | 2.21860921 |
67 | Biconcave vertebral bodies (HP:0004586) | 2.20504339 |
68 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.20359826 |
69 | Mitral valve prolapse (HP:0001634) | 2.18611718 |
70 | Thrombocytosis (HP:0001894) | 2.18427972 |
71 | Hematochezia (HP:0002573) | 2.16381634 |
72 | Vertebral compression fractures (HP:0002953) | 2.16102592 |
73 | Increased IgM level (HP:0003496) | 2.15662995 |
74 | Autoimmune thrombocytopenia (HP:0001973) | 2.14409504 |
75 | Opisthotonus (HP:0002179) | 2.12769656 |
76 | Genu recurvatum (HP:0002816) | 2.12373991 |
77 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.11152647 |
78 | Amyloidosis (HP:0011034) | 2.10059757 |
79 | Increased IgE level (HP:0003212) | 2.10033553 |
80 | J-shaped sella turcica (HP:0002680) | 2.08905686 |
81 | Abnormality of the calcaneus (HP:0008364) | 2.08389085 |
82 | Eosinophilia (HP:0001880) | 2.01400452 |
83 | Emotional lability (HP:0000712) | 2.01348847 |
84 | Panhypogammaglobulinemia (HP:0003139) | 1.99716949 |
85 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.98868285 |
86 | Osteolytic defects of the hand bones (HP:0009699) | 1.98868285 |
87 | Abnormality of T cells (HP:0002843) | 1.98662701 |
88 | Aortic regurgitation (HP:0001659) | 1.98596238 |
89 | Acute hepatic failure (HP:0006554) | 1.98054619 |
90 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.97733829 |
91 | Vacuolated lymphocytes (HP:0001922) | 1.97663846 |
92 | IgM deficiency (HP:0002850) | 1.97516363 |
93 | Spontaneous hematomas (HP:0007420) | 1.96457673 |
94 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.96374951 |
95 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.96374951 |
96 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.96146574 |
97 | Reduced antithrombin III activity (HP:0001976) | 1.96130215 |
98 | Bowel diverticulosis (HP:0005222) | 1.94928602 |
99 | Fatigue (HP:0012378) | 1.93697525 |
100 | Secondary amenorrhea (HP:0000869) | 1.93544902 |
101 | Prolonged bleeding time (HP:0003010) | 1.92393353 |
102 | Abnormality of the common coagulation pathway (HP:0010990) | 1.91931941 |
103 | Mesomelia (HP:0003027) | 1.91402697 |
104 | Small epiphyses (HP:0010585) | 1.90902139 |
105 | Abnormality of the nasal mucosa (HP:0000433) | 1.90508374 |
106 | Bicuspid aortic valve (HP:0001647) | 1.88615144 |
107 | Camptodactyly of toe (HP:0001836) | 1.88167368 |
108 | Aplastic anemia (HP:0001915) | 1.87381991 |
109 | Retinal dysplasia (HP:0007973) | 1.86533707 |
110 | Brittle hair (HP:0002299) | 1.85670189 |
111 | Nasal polyposis (HP:0100582) | 1.84948066 |
112 | Long eyelashes (HP:0000527) | 1.84689155 |
113 | Leukocytosis (HP:0001974) | 1.84146035 |
114 | Atrophic scars (HP:0001075) | 1.84047612 |
115 | Seborrheic dermatitis (HP:0001051) | 1.83219150 |
116 | High pitched voice (HP:0001620) | 1.82498810 |
117 | Hand muscle atrophy (HP:0009130) | 1.81967384 |
118 | Bladder diverticulum (HP:0000015) | 1.79677300 |
119 | B lymphocytopenia (HP:0010976) | 1.78987120 |
120 | Abnormality of B cell number (HP:0010975) | 1.78987120 |
121 | Acute myeloid leukemia (HP:0004808) | 1.78375740 |
122 | Gingival bleeding (HP:0000225) | 1.77936157 |
123 | Broad palm (HP:0001169) | 1.77732693 |
124 | Degeneration of anterior horn cells (HP:0002398) | 1.77569736 |
125 | Abnormality of the anterior horn cell (HP:0006802) | 1.77569736 |
126 | Flexion contracture of toe (HP:0005830) | 1.77372371 |
127 | Joint contractures involving the joints of the feet (HP:0100492) | 1.77372371 |
128 | Abnormality of carpal bone ossification (HP:0006257) | 1.77213863 |
129 | Combined immunodeficiency (HP:0005387) | 1.76928260 |
130 | Broad distal phalanx of finger (HP:0009836) | 1.76786868 |
131 | Dysostosis multiplex (HP:0000943) | 1.76561234 |
132 | Emphysema (HP:0002097) | 1.76257170 |
133 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.76066477 |
134 | Cholelithiasis (HP:0001081) | 1.75900699 |
135 | Increased serum lactate (HP:0002151) | 1.75552116 |
136 | Prolonged partial thromboplastin time (HP:0003645) | 1.75360611 |
137 | Mitochondrial inheritance (HP:0001427) | 1.75021859 |
138 | Increased CSF lactate (HP:0002490) | 1.74908881 |
139 | Vertebral arch anomaly (HP:0008438) | 1.74632652 |
140 | Granulocytopenia (HP:0001913) | 1.74397715 |
141 | Ectopia lentis (HP:0001083) | 1.74212694 |
142 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.72409164 |
143 | Recurrent cutaneous fungal infections (HP:0011370) | 1.72409164 |
144 | Dislocated radial head (HP:0003083) | 1.72386744 |
145 | Proximal placement of thumb (HP:0009623) | 1.71820580 |
146 | Epiphyseal stippling (HP:0010655) | 1.71602465 |
147 | Joint swelling (HP:0001386) | 1.71470301 |
148 | Abnormality of the acetabulum (HP:0003170) | 1.71337767 |
149 | Abnormality of the alveolar ridges (HP:0006477) | 1.71184790 |
150 | Deviation of the hallux (HP:0010051) | 1.71151180 |
151 | Trismus (HP:0000211) | 1.70501071 |
152 | Testicular atrophy (HP:0000029) | 1.69765580 |
153 | Microretrognathia (HP:0000308) | 1.69591642 |
154 | Cerebral palsy (HP:0100021) | 1.69278763 |
155 | Irregular epiphyses (HP:0010582) | 1.69207754 |
156 | Broad face (HP:0000283) | 1.68711555 |
157 | Abnormality of methionine metabolism (HP:0010901) | 1.68502799 |
158 | Increased intramyocellular lipid droplets (HP:0012240) | 1.67574199 |
159 | Ulnar bowing (HP:0003031) | 1.66631406 |
160 | Thoracolumbar scoliosis (HP:0002944) | 1.66283926 |
161 | Hemorrhage of the eye (HP:0011885) | 1.66171212 |
162 | Hypercholesterolemia (HP:0003124) | 1.66161365 |
163 | Vascular tortuosity (HP:0004948) | 1.66155388 |
164 | Interstitial pulmonary disease (HP:0006530) | 1.65627224 |
165 | Hallux valgus (HP:0001822) | 1.65615999 |
166 | Mesangial abnormality (HP:0001966) | 1.65280950 |
167 | Abnormality of the 4th metacarpal (HP:0010012) | 1.65259562 |
168 | Recurrent abscess formation (HP:0002722) | 1.64959790 |
169 | Abnormality of the fingertips (HP:0001211) | 1.64804513 |
170 | Dicarboxylic aciduria (HP:0003215) | 1.64733000 |
171 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.64733000 |
172 | Hypoplasia of the thymus (HP:0000778) | 1.64299325 |
173 | Deviation of the thumb (HP:0009603) | 1.64176756 |
174 | Agammaglobulinemia (HP:0004432) | 1.64047584 |
175 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.63982305 |
176 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.63982305 |
177 | Short nail (HP:0001799) | 1.63537988 |
178 | Increased muscle lipid content (HP:0009058) | 1.63117690 |
179 | Abnormality of the radial head (HP:0003995) | 1.63088411 |
180 | Adrenal hypoplasia (HP:0000835) | 1.63062789 |
181 | Squamous cell carcinoma (HP:0002860) | 1.62683107 |
182 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.62519212 |
183 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.62519212 |
184 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.62519212 |
185 | Exercise intolerance (HP:0003546) | 1.61708153 |
186 | Slender build (HP:0001533) | 1.61467248 |
187 | Distal upper limb amyotrophy (HP:0007149) | 1.61409899 |
188 | Meningitis (HP:0001287) | 1.61178031 |
189 | Mitral regurgitation (HP:0001653) | 1.61152018 |
190 | Increased connective tissue (HP:0009025) | 1.60123688 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TIE1 | 5.23485870 |
2 | VRK2 | 4.60893091 |
3 | EEF2K | 3.41780149 |
4 | BCKDK | 3.31015239 |
5 | EPHA2 | 2.77333018 |
6 | MAP4K1 | 2.68710757 |
7 | MAP4K2 | 2.51636022 |
8 | TRIB3 | 2.31923742 |
9 | STK10 | 2.28160625 |
10 | LRRK2 | 2.25541538 |
11 | SMG1 | 2.14414977 |
12 | SIK3 | 2.08706253 |
13 | KDR | 2.07712310 |
14 | LIMK1 | 2.05600475 |
15 | TEC | 1.93249562 |
16 | BMX | 1.89940826 |
17 | MAPKAPK3 | 1.87279949 |
18 | TTN | 1.85306436 |
19 | PKN2 | 1.82227362 |
20 | TRPM7 | 1.80131846 |
21 | CDC7 | 1.80085075 |
22 | RPS6KA4 | 1.74782719 |
23 | TYK2 | 1.74232312 |
24 | MAP3K10 | 1.72135405 |
25 | SRPK1 | 1.70934755 |
26 | TGFBR1 | 1.70127196 |
27 | JAK3 | 1.64954033 |
28 | IRAK3 | 1.59882705 |
29 | NEK2 | 1.55816771 |
30 | TRIM28 | 1.53415755 |
31 | CDK12 | 1.51009954 |
32 | ERN1 | 1.50834429 |
33 | TSSK6 | 1.50488178 |
34 | ZAP70 | 1.50244878 |
35 | DAPK1 | 1.49619437 |
36 | CDK19 | 1.38145972 |
37 | SIK2 | 1.33434267 |
38 | RPS6KB2 | 1.33085354 |
39 | NME2 | 1.30967409 |
40 | CDK8 | 1.28181560 |
41 | CLK1 | 1.27030895 |
42 | MST1R | 1.26506644 |
43 | ACVR1B | 1.25136759 |
44 | PLK4 | 1.21636728 |
45 | PAK4 | 1.18746130 |
46 | PDGFRA | 1.17812618 |
47 | BLK | 1.16773576 |
48 | NLK | 1.16605225 |
49 | MAP2K3 | 1.16541099 |
50 | TGFBR2 | 1.12493797 |
51 | BUB1 | 1.10636855 |
52 | FGFR4 | 1.09247935 |
53 | LMTK2 | 1.08770307 |
54 | PASK | 1.07267780 |
55 | WEE1 | 1.07237557 |
56 | MAP2K6 | 1.06520206 |
57 | JAK1 | 1.06221573 |
58 | ICK | 1.06185776 |
59 | VRK1 | 1.06044846 |
60 | GRK6 | 1.05520997 |
61 | FGFR3 | 1.05427375 |
62 | BTK | 1.04643824 |
63 | TXK | 1.03435627 |
64 | NME1 | 1.03386687 |
65 | TBK1 | 1.03016826 |
66 | CSNK1G3 | 1.02486633 |
67 | MAPK11 | 1.00727202 |
68 | CDK9 | 0.99441437 |
69 | MAP3K8 | 0.97347925 |
70 | ERBB3 | 0.94986147 |
71 | KIT | 0.94224911 |
72 | PTK6 | 0.93696331 |
73 | ITK | 0.87493175 |
74 | CSF1R | 0.87067357 |
75 | FLT3 | 0.86608276 |
76 | PIM2 | 0.86249615 |
77 | IKBKB | 0.86004040 |
78 | TESK2 | 0.85646210 |
79 | PIM1 | 0.85151925 |
80 | CSNK1A1L | 0.80897127 |
81 | CDK4 | 0.80582126 |
82 | BCR | 0.79536437 |
83 | PAK2 | 0.78692657 |
84 | TNK2 | 0.78593427 |
85 | PBK | 0.78354652 |
86 | CDK6 | 0.77853284 |
87 | AURKA | 0.76446911 |
88 | DMPK | 0.75341445 |
89 | HCK | 0.73611008 |
90 | CDK7 | 0.73223625 |
91 | IKBKE | 0.72558789 |
92 | TLK1 | 0.72551621 |
93 | LATS2 | 0.70989251 |
94 | CAMK1D | 0.69911450 |
95 | MST4 | 0.69176637 |
96 | MTOR | 0.69114258 |
97 | ARAF | 0.68350294 |
98 | NUAK1 | 0.68103623 |
99 | RPS6KC1 | 0.66404466 |
100 | RPS6KL1 | 0.66404466 |
101 | RPS6KA6 | 0.65202484 |
102 | CHUK | 0.64886079 |
103 | CSK | 0.64578222 |
104 | SIK1 | 0.63485270 |
105 | BRSK2 | 0.61797062 |
106 | LCK | 0.61484571 |
107 | STK3 | 0.61430293 |
108 | SCYL2 | 0.61106092 |
109 | DYRK1B | 0.60561676 |
110 | NEK1 | 0.59765023 |
111 | MAP2K7 | 0.58415565 |
112 | STK4 | 0.58107345 |
113 | PTK2 | 0.57866790 |
114 | MKNK1 | 0.57397831 |
115 | MAP3K11 | 0.57110278 |
116 | ZAK | 0.55848329 |
117 | EIF2AK1 | 0.55764129 |
118 | MAPKAPK2 | 0.55362884 |
119 | MAP3K6 | 0.54535923 |
120 | PDGFRB | 0.53612232 |
121 | PDK2 | 0.53387209 |
122 | PRKD2 | 0.53154607 |
123 | TAOK2 | 0.52363375 |
124 | MAP3K14 | 0.51875986 |
125 | MET | 0.51329471 |
126 | EPHB2 | 0.51108986 |
127 | AURKB | 0.50500534 |
128 | ATR | 0.49824630 |
129 | MAP2K2 | 0.49223768 |
130 | IRAK4 | 0.48112634 |
131 | MAP3K5 | 0.46496232 |
132 | PLK1 | 0.46292786 |
133 | CSNK1G1 | 0.45373777 |
134 | BRSK1 | 0.44669998 |
135 | STK16 | 0.44498979 |
136 | SYK | 0.44460059 |
137 | EPHA3 | 0.44181588 |
138 | EPHB1 | 0.43620148 |
139 | PRKCI | 0.41732582 |
140 | MAP3K3 | 0.41706855 |
141 | TESK1 | 0.40866078 |
142 | ALK | 0.40389343 |
143 | RIPK1 | 0.39546492 |
144 | TAF1 | 0.35751197 |
145 | HIPK2 | 0.35533319 |
146 | CDK14 | 0.34589413 |
147 | ABL2 | 0.33017067 |
148 | PAK1 | 0.32636864 |
149 | EIF2AK2 | 0.32356441 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.67142554 |
2 | DNA replication_Homo sapiens_hsa03030 | 2.65610650 |
3 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.46939647 |
4 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 2.29940618 |
5 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.29598965 |
6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.24144651 |
7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.13972234 |
8 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.02639820 |
9 | Mismatch repair_Homo sapiens_hsa03430 | 1.93815238 |
10 | Leishmaniasis_Homo sapiens_hsa05140 | 1.85369116 |
11 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.83833440 |
12 | Cell cycle_Homo sapiens_hsa04110 | 1.81252808 |
13 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.80266053 |
14 | Carbon metabolism_Homo sapiens_hsa01200 | 1.79227606 |
15 | Galactose metabolism_Homo sapiens_hsa00052 | 1.77930169 |
16 | Spliceosome_Homo sapiens_hsa03040 | 1.76195789 |
17 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.73448124 |
18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.72633212 |
19 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.71979389 |
20 | Ribosome_Homo sapiens_hsa03010 | 1.71548012 |
21 | Adherens junction_Homo sapiens_hsa04520 | 1.68360859 |
22 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.62902381 |
23 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.61290313 |
24 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.60954657 |
25 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.59820834 |
26 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.59390897 |
27 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.59323185 |
28 | Shigellosis_Homo sapiens_hsa05131 | 1.59021958 |
29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.55298568 |
30 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.51558020 |
31 | HTLV-I infection_Homo sapiens_hsa05166 | 1.51527262 |
32 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.51251950 |
33 | Measles_Homo sapiens_hsa05162 | 1.51012361 |
34 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.48980115 |
35 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.48503389 |
36 | Base excision repair_Homo sapiens_hsa03410 | 1.46250365 |
37 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.45339267 |
38 | Sulfur relay system_Homo sapiens_hsa04122 | 1.41940503 |
39 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.40289943 |
40 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.39671310 |
41 | RNA transport_Homo sapiens_hsa03013 | 1.39242208 |
42 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.37634317 |
43 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.37180871 |
44 | Hepatitis B_Homo sapiens_hsa05161 | 1.34232373 |
45 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.32914439 |
46 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.32330828 |
47 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.32182550 |
48 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.32096649 |
49 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.31438413 |
50 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.31067252 |
51 | Focal adhesion_Homo sapiens_hsa04510 | 1.29014540 |
52 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.28629398 |
53 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.27600396 |
54 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.27131877 |
55 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.25426269 |
56 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.22807816 |
57 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.22593028 |
58 | Apoptosis_Homo sapiens_hsa04210 | 1.21337322 |
59 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.21006917 |
60 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.20503408 |
61 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.20153670 |
62 | Homologous recombination_Homo sapiens_hsa03440 | 1.19996686 |
63 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.19111828 |
64 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.17213819 |
65 | Malaria_Homo sapiens_hsa05144 | 1.15964719 |
66 | Viral myocarditis_Homo sapiens_hsa05416 | 1.15265812 |
67 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.14957018 |
68 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.14793710 |
69 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.14103187 |
70 | Platelet activation_Homo sapiens_hsa04611 | 1.12974011 |
71 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.12828963 |
72 | Thyroid cancer_Homo sapiens_hsa05216 | 1.10083387 |
73 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.09064502 |
74 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.07627499 |
75 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.06459461 |
76 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.05702588 |
77 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.04494712 |
78 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.04290766 |
79 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.02280813 |
80 | Colorectal cancer_Homo sapiens_hsa05210 | 1.01021994 |
81 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.01004804 |
82 | RNA degradation_Homo sapiens_hsa03018 | 1.00413554 |
83 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.00029089 |
84 | Legionellosis_Homo sapiens_hsa05134 | 0.97778422 |
85 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.97112518 |
86 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.95402036 |
87 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.94471628 |
88 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.94395004 |
89 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.94251219 |
90 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.93791447 |
91 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.91697621 |
92 | Bladder cancer_Homo sapiens_hsa05219 | 0.91138310 |
93 | Prostate cancer_Homo sapiens_hsa05215 | 0.90791377 |
94 | Peroxisome_Homo sapiens_hsa04146 | 0.90706894 |
95 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.87591092 |
96 | Influenza A_Homo sapiens_hsa05164 | 0.84819848 |
97 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.83970862 |
98 | Purine metabolism_Homo sapiens_hsa00230 | 0.83459352 |
99 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.83326429 |
100 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.82310337 |
101 | Pathways in cancer_Homo sapiens_hsa05200 | 0.81143628 |
102 | Salmonella infection_Homo sapiens_hsa05132 | 0.79400969 |
103 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.78909964 |
104 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.77047029 |
105 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.76192520 |
106 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.74351713 |
107 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.74035217 |
108 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.73697982 |
109 | Tuberculosis_Homo sapiens_hsa05152 | 0.72977021 |
110 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.72946558 |
111 | Pertussis_Homo sapiens_hsa05133 | 0.72543572 |
112 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.71746240 |
113 | Proteasome_Homo sapiens_hsa03050 | 0.71096088 |
114 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.70140715 |
115 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.69846232 |
116 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.69631875 |
117 | Amoebiasis_Homo sapiens_hsa05146 | 0.69447220 |
118 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.68985651 |
119 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.68887805 |
120 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.68791208 |
121 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.68204670 |
122 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67208866 |
123 | RNA polymerase_Homo sapiens_hsa03020 | 0.63197541 |
124 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.62651292 |
125 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.61938337 |
126 | Endometrial cancer_Homo sapiens_hsa05213 | 0.61770018 |
127 | Hepatitis C_Homo sapiens_hsa05160 | 0.61732978 |
128 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.61002092 |
129 | Lysosome_Homo sapiens_hsa04142 | 0.60873273 |
130 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.60532761 |
131 | Metabolic pathways_Homo sapiens_hsa01100 | 0.60175396 |
132 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.59983801 |
133 | Allograft rejection_Homo sapiens_hsa05330 | 0.59505328 |
134 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.59426040 |
135 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.59257034 |
136 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.58966935 |
137 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.58634721 |
138 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.57145282 |
139 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.56898364 |
140 | Protein export_Homo sapiens_hsa03060 | 0.55616256 |
141 | Basal transcription factors_Homo sapiens_hsa03022 | 0.51096741 |
142 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.50724163 |
143 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.50115390 |
144 | Parkinsons disease_Homo sapiens_hsa05012 | 0.49523795 |
145 | Endocytosis_Homo sapiens_hsa04144 | 0.47641161 |
146 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.45757057 |
147 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.45359801 |
148 | Lysine degradation_Homo sapiens_hsa00310 | 0.45253055 |
149 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.39906414 |
150 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.37698132 |
151 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.36958753 |
152 | Huntingtons disease_Homo sapiens_hsa05016 | 0.35518351 |
153 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.32988448 |